Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Cannabinoid dependence induces sustained changes in GABA release in the globus pallidus without affecting dopamine release in the dorsal striatum: A dual microdialysis probe study.

Moreno M, Decara J, Pavon FJ, Stouffer DG, Edwards S, Serrano A, Suárez J, Parsons LH, Rodríguez de Fonseca F.

Addict Biol. 2018 Nov;23(6):1251-1261. doi: 10.1111/adb.12694. Epub 2018 Nov 13.

PMID:
30421559
2.

Ethanol-induced alterations in endocannabinoids and relevant neurotransmitters in the nucleus accumbens of fatty acid amide hydrolase knockout mice.

Pavón FJ, Serrano A, Stouffer DG, Polis I, Roberto M, Cravatt BF, Martin-Fardon R, Rodríguez de Fonseca F, Parsons LH.

Addict Biol. 2018 Nov 13. doi: 10.1111/adb.12695. [Epub ahead of print]

PMID:
30421483
3.

The Lateral Habenula Directs Coping Styles Under Conditions of Stress via Recruitment of the Endocannabinoid System.

Berger AL, Henricks AM, Lugo JM, Wright HR, Warrick CR, Sticht MA, Morena M, Bonilla I, Laredo SA, Craft RM, Parsons LH, Grandes PR, Hillard CJ, Hill MN, McLaughlin RJ.

Biol Psychiatry. 2018 Oct 15;84(8):611-623. doi: 10.1016/j.biopsych.2018.04.018. Epub 2018 May 8.

PMID:
29887035
4.

Deficient endocannabinoid signaling in the central amygdala contributes to alcohol dependence-related anxiety-like behavior and excessive alcohol intake.

Serrano A, Pavon FJ, Buczynski MW, Schlosburg J, Natividad LA, Polis IY, Stouffer DG, Zorrilla EP, Roberto M, Cravatt BF, Martin-Fardon R, Rodriguez de Fonseca F, Parsons LH.

Neuropsychopharmacology. 2018 Aug;43(9):1840-1850. doi: 10.1038/s41386-018-0055-3. Epub 2018 Apr 5.

5.

Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle.

Gonzalez-Cuevas G, Martin-Fardon R, Kerr TM, Stouffer DG, Parsons LH, Hammell DC, Banks SL, Stinchcomb AL, Weiss F.

Neuropsychopharmacology. 2018 Sep;43(10):2036-2045. doi: 10.1038/s41386-018-0050-8. Epub 2018 Mar 22.

6.

The prevalence of occult endometrial cancer in women undergoing hysterectomy for benign indications.

Parsons LHP, Pedersen R, Richardson DL, Kho KA.

Eur J Obstet Gynecol Reprod Biol. 2018 Apr;223:108-112. doi: 10.1016/j.ejogrb.2018.02.017. Epub 2018 Feb 21.

PMID:
29518640
7.

Phosphorylation of calcium/calmodulin-dependent protein kinase II in the rat dorsal medial prefrontal cortex is associated with alcohol-induced cognitive inflexibility.

Natividad LA, Steinman MQ, Laredo SA, Irimia C, Polis IY, Lintz R, Buczynski MW, Martin-Fardon R, Roberto M, Parsons LH.

Addict Biol. 2018 Sep;23(5):1117-1129. doi: 10.1111/adb.12568. Epub 2017 Sep 22.

8.

Fatty acid amide hydrolase (FAAH) inactivation confers enhanced sensitivity to nicotine-induced dopamine release in the mouse nucleus accumbens.

Pavon FJ, Serrano A, Sidhpura N, Polis I, Stouffer D, de Fonseca FR, Cravatt BF, Martin-Fardon R, Parsons LH.

Addict Biol. 2018 Mar;23(2):723-734. doi: 10.1111/adb.12531. Epub 2017 Jun 29.

9.

CB1 and ethanol effects on glutamatergic transmission in the central amygdala of male and female msP and Wistar rats.

Kirson D, Oleata CS, Parsons LH, Ciccocioppo R, Roberto M.

Addict Biol. 2018 Mar;23(2):676-688. doi: 10.1111/adb.12525. Epub 2017 Jun 28.

10.

Central Nervous System Infection with Borna Disease Virus Causes Kynurenine Pathway Dysregulation and Neurotoxic Quinolinic Acid Production.

Formisano S, Hornig M, Yaddanapudi K, Vasishtha M, Parsons LH, Briese T, Lipkin WI, Williams BL.

J Virol. 2017 Jun 26;91(14). pii: e00673-17. doi: 10.1128/JVI.00673-17. Print 2017 Jul 15.

11.

Constitutive Increases in Amygdalar Corticotropin-Releasing Factor and Fatty Acid Amide Hydrolase Drive an Anxious Phenotype.

Natividad LA, Buczynski MW, Herman MA, Kirson D, Oleata CS, Irimia C, Polis I, Ciccocioppo R, Roberto M, Parsons LH.

Biol Psychiatry. 2017 Oct 1;82(7):500-510. doi: 10.1016/j.biopsych.2017.01.005. Epub 2017 Jan 13.

12.

Dysregulated Glycine Signaling Contributes to Increased Impulsivity during Protracted Alcohol Abstinence.

Irimia C, Buczynski MW, Natividad LA, Laredo SA, Avalos N, Parsons LH.

J Neurosci. 2017 Feb 15;37(7):1853-1861. doi: 10.1523/JNEUROSCI.2466-16.2017.

13.

Physiological processes underlying organ injury in alcohol abuse.

Souza-Smith FM, Lang CH, Nagy LE, Bailey SM, Parsons LH, Murray GJ.

Am J Physiol Endocrinol Metab. 2016 Sep 1;311(3):E605-19. doi: 10.1152/ajpendo.00270.2016. Epub 2016 Jul 19. Review.

14.

Inhaled delivery of Δ(9)-tetrahydrocannabinol (THC) to rats by e-cigarette vapor technology.

Nguyen JD, Aarde SM, Vandewater SA, Grant Y, Stouffer DG, Parsons LH, Cole M, Taffe MA.

Neuropharmacology. 2016 Oct;109:112-120. doi: 10.1016/j.neuropharm.2016.05.021. Epub 2016 May 30.

15.

Keep off the grass? Cannabis, cognition and addiction.

Curran HV, Freeman TP, Mokrysz C, Lewis DA, Morgan CJ, Parsons LH.

Nat Rev Neurosci. 2016 May;17(5):293-306. doi: 10.1038/nrn.2016.28. Epub 2016 Apr 7. Review.

PMID:
27052382
16.

Diacylglycerol lipase disinhibits VTA dopamine neurons during chronic nicotine exposure.

Buczynski MW, Herman MA, Hsu KL, Natividad LA, Irimia C, Polis IY, Pugh H, Chang JW, Niphakis MJ, Cravatt BF, Roberto M, Parsons LH.

Proc Natl Acad Sci U S A. 2016 Jan 26;113(4):1086-91. doi: 10.1073/pnas.1522672113. Epub 2016 Jan 11.

17.

Endocannabinoid signalling in reward and addiction.

Parsons LH, Hurd YL.

Nat Rev Neurosci. 2015 Oct;16(10):579-94. doi: 10.1038/nrn4004. Epub 2015 Sep 16. Review.

18.

Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid.

De Luca MA, Bimpisidis Z, Melis M, Marti M, Caboni P, Valentini V, Margiani G, Pintori N, Polis I, Marsicano G, Parsons LH, Di Chiara G.

Neuropharmacology. 2015 Dec;99:705-14. doi: 10.1016/j.neuropharm.2015.08.041. Epub 2015 Oct 23.

PMID:
26327678
19.

Role of the satiety factor oleoylethanolamide in alcoholism.

Bilbao A, Serrano A, Cippitelli A, Pavón FJ, Giuffrida A, Suárez J, García-Marchena N, Baixeras E, Gómez de Heras R, Orio L, Alén F, Ciccocioppo R, Cravatt BF, Parsons LH, Piomelli D, Rodríguez de Fonseca F.

Addict Biol. 2016 Jul;21(4):859-72. doi: 10.1111/adb.12276. Epub 2015 Jun 2.

20.

GIRK3 gates activation of the mesolimbic dopaminergic pathway by ethanol.

Herman MA, Sidhu H, Stouffer DG, Kreifeldt M, Le D, Cates-Gatto C, Munoz MB, Roberts AJ, Parsons LH, Roberto M, Wickman K, Slesinger PA, Contet C.

Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):7091-6. doi: 10.1073/pnas.1416146112. Epub 2015 May 11.

21.

Chronic ethanol exposure decreases CB1 receptor function at GABAergic synapses in the rat central amygdala.

Varodayan FP, Soni N, Bajo M, Luu G, Madamba SG, Schweitzer P, Parsons LH, Roberto M.

Addict Biol. 2016 Jul;21(4):788-801. doi: 10.1111/adb.12256. Epub 2015 May 5.

22.

Persistent effects of chronic Δ9-THC exposure on motor impulsivity in rats.

Irimia C, Polis IY, Stouffer D, Parsons LH.

Psychopharmacology (Berl). 2015 Aug;232(16):3033-43. doi: 10.1007/s00213-015-3942-x. Epub 2015 Apr 30.

PMID:
25925779
23.

Impaired response inhibition in the rat 5 choice continuous performance task during protracted abstinence from chronic alcohol consumption.

Irimia C, Tuong RN, Quach T, Parsons LH.

PLoS One. 2014 Oct 15;9(10):e109948. doi: 10.1371/journal.pone.0109948. eCollection 2014.

24.

Increased impulsivity in rats as a result of repeated cycles of alcohol intoxication and abstinence.

Irimia C, Wiskerke J, Natividad LA, Polis IY, de Vries TJ, Pattij T, Parsons LH.

Addict Biol. 2015 Mar;20(2):263-74. doi: 10.1111/adb.12119. Epub 2013 Dec 17.

25.

The systemic administration of oleoylethanolamide exerts neuroprotection of the nigrostriatal system in experimental Parkinsonism.

Gonzalez-Aparicio R, Blanco E, Serrano A, Pavon FJ, Parsons LH, Maldonado R, Robledo P, Fernandez-Espejo E, de Fonseca FR.

Int J Neuropsychopharmacol. 2014 Mar;17(3):455-68. doi: 10.1017/S1461145713001259. Epub 2013 Oct 29.

26.

Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss.

Talantova M, Sanz-Blasco S, Zhang X, Xia P, Akhtar MW, Okamoto S, Dziewczapolski G, Nakamura T, Cao G, Pratt AE, Kang YJ, Tu S, Molokanova E, McKercher SR, Hires SA, Sason H, Stouffer DG, Buczynski MW, Solomon JP, Michael S, Powers ET, Kelly JW, Roberts A, Tong G, Fang-Newmeyer T, Parker J, Holland EA, Zhang D, Nakanishi N, Chen HS, Wolosker H, Wang Y, Parsons LH, Ambasudhan R, Masliah E, Heinemann SF, Piña-Crespo JC, Lipton SA.

Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):E2518-27. doi: 10.1073/pnas.1306832110. Epub 2013 Jun 17. Erratum in: Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13691. Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):E3630. Proc Natl Acad Sci U S A. 2015 Jul 14;112(28):E3751-2.

27.

Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors.

Niphakis MJ, Cognetta AB 3rd, Chang JW, Buczynski MW, Parsons LH, Byrne F, Burston JJ, Chapman V, Cravatt BF.

ACS Chem Neurosci. 2013 Sep 18;4(9):1322-32. doi: 10.1021/cn400116z. Epub 2013 Jun 17.

28.

Δ(9)Tetrahydrocannabinol impairs reversal learning but not extra-dimensional shifts in rhesus macaques.

Wright MJ Jr, Vandewater SA, Parsons LH, Taffe MA.

Neuroscience. 2013 Apr 3;235:51-8. doi: 10.1016/j.neuroscience.2013.01.018. Epub 2013 Jan 16.

29.

The volitional nature of nicotine exposure alters anandamide and oleoylethanolamide levels in the ventral tegmental area.

Buczynski MW, Polis IY, Parsons LH.

Neuropsychopharmacology. 2013 Mar;38(4):574-84. doi: 10.1038/npp.2012.210. Epub 2012 Nov 21.

30.

Effect of ambient temperature on the thermoregulatory and locomotor stimulant effects of 4-methylmethcathinone in Wistar and Sprague-Dawley rats.

Wright MJ Jr, Angrish D, Aarde SM, Barlow DJ, Buczynski MW, Creehan KM, Vandewater SA, Parsons LH, Houseknecht KL, Dickerson TJ, Taffe MA.

PLoS One. 2012;7(8):e44652. doi: 10.1371/journal.pone.0044652. Epub 2012 Aug 31.

31.

Adolescent rats are resistant to adaptations in excitatory and inhibitory mechanisms that modulate mesolimbic dopamine during nicotine withdrawal.

Natividad LA, Buczynski MW, Parsons LH, Torres OV, O'Dell LE.

J Neurochem. 2012 Nov;123(4):578-88. doi: 10.1111/j.1471-4159.2012.07926.x. Epub 2012 Oct 1.

32.

Characterization of the effects of reuptake and hydrolysis inhibition on interstitial endocannabinoid levels in the brain: an in vivo microdialysis study.

Wiskerke J, Irimia C, Cravatt BF, De Vries TJ, Schoffelmeer AN, Pattij T, Parsons LH.

ACS Chem Neurosci. 2012 May 16;3(5):407-17. doi: 10.1021/cn300036b. Epub 2012 Apr 22.

33.

The role of fatty acid amide hydrolase inhibition in nicotine reward and dependence.

Muldoon PP, Lichtman AH, Parsons LH, Damaj MI.

Life Sci. 2013 Mar 19;92(8-9):458-62. doi: 10.1016/j.lfs.2012.05.015. Epub 2012 Jun 12. Review.

34.

Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates.

Chang JW, Niphakis MJ, Lum KM, Cognetta AB 3rd, Wang C, Matthews ML, Niessen S, Buczynski MW, Parsons LH, Cravatt BF.

Chem Biol. 2012 May 25;19(5):579-88. doi: 10.1016/j.chembiol.2012.03.009. Epub 2012 Apr 26.

35.

Differential effects of single versus repeated alcohol withdrawal on the expression of endocannabinoid system-related genes in the rat amygdala.

Serrano A, Rivera P, Pavon FJ, Decara J, Suárez J, Rodriguez de Fonseca F, Parsons LH.

Alcohol Clin Exp Res. 2012 Jun;36(6):984-94. doi: 10.1111/j.1530-0277.2011.01686.x. Epub 2011 Dec 5.

36.

Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.

Serrano A, Parsons LH.

Pharmacol Ther. 2011 Dec;132(3):215-41. doi: 10.1016/j.pharmthera.2011.06.005. Epub 2011 Jul 18. Review.

37.

Endocannabinoid-mediated synaptic plasticity and addiction-related behavior.

Sidhpura N, Parsons LH.

Neuropharmacology. 2011 Dec;61(7):1070-87. doi: 10.1016/j.neuropharm.2011.05.034. Epub 2011 Jun 12. Review.

38.

Methamphetamine and lentivirus interactions: reciprocal enhancement of central nervous system disease.

Huitron-Resendiz S, Henriksen SJ, Barr MC, Testa MP, Crawford E, Parsons LH, Sanchez-Alavez M, Phillips TR.

J Neurovirol. 2010 Jul;16(4):268-78. doi: 10.3109/13550284.2010.497807.

PMID:
20608774
39.

Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls.

Buczynski MW, Parsons LH.

Br J Pharmacol. 2010 Jun;160(3):423-42. doi: 10.1111/j.1476-5381.2010.00787.x. Review.

40.

A genetic determinant of the striatal dopamine response to alcohol in men.

Ramchandani VA, Umhau J, Pavon FJ, Ruiz-Velasco V, Margas W, Sun H, Damadzic R, Eskay R, Schoor M, Thorsell A, Schwandt ML, Sommer WH, George DT, Parsons LH, Herscovitch P, Hommer D, Heilig M.

Mol Psychiatry. 2011 Aug;16(8):809-17. doi: 10.1038/mp.2010.56. Epub 2010 May 18.

41.

The endocannabinoid system tonically regulates inhibitory transmission and depresses the effect of ethanol in central amygdala.

Roberto M, Cruz M, Bajo M, Siggins GR, Parsons LH, Schweitzer P.

Neuropsychopharmacology. 2010 Aug;35(9):1962-72. doi: 10.1038/npp.2010.70. Epub 2010 May 12.

42.

Corticotropin releasing factor-induced amygdala gamma-aminobutyric Acid release plays a key role in alcohol dependence.

Roberto M, Cruz MT, Gilpin NW, Sabino V, Schweitzer P, Bajo M, Cottone P, Madamba SG, Stouffer DG, Zorrilla EP, Koob GF, Siggins GR, Parsons LH.

Biol Psychiatry. 2010 May 1;67(9):831-9. doi: 10.1016/j.biopsych.2009.11.007. Epub 2010 Jan 8.

43.

Effects of the endogenous PPAR-alpha agonist, oleoylethanolamide on MDMA-induced cognitive deficits in mice.

Plaza-Zabala A, Berrendero F, Suarez J, Bermudez-Silva FJ, Fernandez-Espejo E, Serrano A, Pavon FJ, Parsons LH, De Fonseca FR, Maldonado R, Robledo P.

Synapse. 2010 May;64(5):379-89. doi: 10.1002/syn.20733.

PMID:
20029832
44.

Neural basis for a heritable phenotype: differences in the effects of apomorphine on startle gating and ventral pallidal GABA efflux in male Sprague-Dawley and Long-Evans rats.

Qu Y, Saint Marie RL, Breier MR, Ko D, Stouffer D, Parsons LH, Swerdlow NR.

Psychopharmacology (Berl). 2009 Dec;207(2):271-80. doi: 10.1007/s00213-009-1654-9. Epub 2009 Sep 16.

45.

Acquisition of and withdrawal from cocaine self-administration regulates 5-HT mRNA expression in rat striatum.

Neumaier JF, McDevitt RA, Polis IY, Parsons LH.

J Neurochem. 2009 Oct;111(1):217-27. doi: 10.1111/j.1471-4159.2009.06313.x. Epub 2009 Jul 30.

46.

Chronic ethanol treatment potentiates ethanol-induced increases in interstitial nucleus accumbens endocannabinoid levels in rats.

Alvarez-Jaimes L, Stouffer DG, Parsons LH.

J Neurochem. 2009 Oct;111(1):37-48. doi: 10.1111/j.1471-4159.2009.06301.x. Epub 2009 Jul 23.

47.

Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway function.

Abdallah L, Bonasera SJ, Hopf FW, O'Dell L, Giorgetti M, Jongsma M, Carra S, Pierucci M, Di Giovanni G, Esposito E, Parsons LH, Bonci A, Tecott LH.

J Neurosci. 2009 Jun 24;29(25):8156-65. doi: 10.1523/JNEUROSCI.3905-08.2009.

48.

A role for the endocannabinoid system in the increased motivation for cocaine in extended-access conditions.

Orio L, Edwards S, George O, Parsons LH, Koob GF.

J Neurosci. 2009 Apr 15;29(15):4846-57. doi: 10.1523/JNEUROSCI.0563-09.2009.

49.

Central cannabinoid 1 receptor antagonist administration prevents endotoxic hypotension affecting norepinephrine release in the preoptic anterior hypothalamic area.

Villanueva A, Yilmaz SM, Millington WR, Cutrera RA, Stouffer DG, Parsons LH, Cheer JF, Feleder C.

Shock. 2009 Dec;32(6):614-20. doi: 10.1097/SHK.0b013e3181a4fd8f.

50.

Regional Influence of Cannabinoid CB1 Receptors in the Regulation of Ethanol Self-Administration by Wistar Rats.

Alvarez-Jaimes L, Polis I, Parsons LH.

Open Neuropsychopharmacol J. 2009;2:77-85.

Supplemental Content

Loading ...
Support Center